Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, April 15, 2021
[ Thu, Apr 15th 2021
] - WOPRAI
[ Thu, Apr 15th 2021
] - WOPRAI
[ Thu, Apr 15th 2021
] - WOPRAI
[ Thu, Apr 15th 2021
] - WOPRAI
[ Thu, Apr 15th 2021
] - WOPRAI
[ Thu, Apr 15th 2021
] - WOPRAI
[ Thu, Apr 15th 2021
] - WOPRAI
[ Thu, Apr 15th 2021
] - WOPRAI
[ Thu, Apr 15th 2021
] - WOPRAI
[ Thu, Apr 15th 2021
] - WOPRAI
[ Thu, Apr 15th 2021
] - WOPRAI
[ Thu, Apr 15th 2021
] - WOPRAI
[ Thu, Apr 15th 2021
] - WOPRAI
[ Thu, Apr 15th 2021
] - WOPRAI
[ Thu, Apr 15th 2021
] - WOPRAI
[ Thu, Apr 15th 2021
] - WOPRAI
[ Thu, Apr 15th 2021
] - WOPRAI
[ Thu, Apr 15th 2021
] - WOPRAI
[ Thu, Apr 15th 2021
] - WOPRAI
[ Thu, Apr 15th 2021
] - WOPRAI
[ Thu, Apr 15th 2021
] - WOPRAI
[ Thu, Apr 15th 2021
] - WOPRAI
[ Thu, Apr 15th 2021
] - WOPRAI
[ Thu, Apr 15th 2021
] - WOPRAI
[ Thu, Apr 15th 2021
] - WOPRAI
[ Thu, Apr 15th 2021
] - WOPRAI
[ Thu, Apr 15th 2021
] - WOPRAI
[ Thu, Apr 15th 2021
] - WOPRAI
Max Masucci Initiated (XGN) at Strong Buy and Held Target at $25 on, Apr 15th, 2021
Max Masucci of Canaccord Genuity, Initiated "Exagen Inc." (XGN) at Strong Buy and Held Target at $25 on, Apr 15th, 2021.
Max has made no other calls on XGN in the last 4 months.
There is 1 other peer that has a rating on XGN. Out of the 1 peers that are also analyzing XGN, 0 agree with Max's Rating of Hold.
This is the rating of the analyst that currently disagrees with Max
- Paul Knight of "Keybanc" Maintained at Buy with Increased Target to $33 on, Tuesday, March 2nd, 2021
